Variable phenotypes are associated with PMP22 missense mutations.

Area of Science:

• Genetics
• Neurology
• Molecular Biology

Background:

• Charcot-Marie-Tooth disease (CMT) is a common inherited neurological disorder with diverse genetic causes.
• CMT type 1A (CMT1A), the most frequent form, typically results from a PMP22 gene duplication on chromosome 17.
• PMP22 gene mutations represent a less common etiology for CMT.

Observation:

• This study analyzed 10 patients with PMP22 missense mutations, detailing their clinical, electrophysiological, and molecular profiles.
• Six distinct point mutations were identified, including two previously undescribed mutations.
• A specific mutation, Thr118Met in the PMP22 gene, was found in three families.

Findings:

• PMP22 missense mutations present a spectrum of phenotypes, ranging from mild hereditary neuropathy with liability to pressure palsies (HNPP) to severe CMT1.
• The identified mutations demonstrate the diverse clinical manifestations associated with PMP22 point mutations.
• The Thr118Met mutation is confirmed to be associated with neuropathy, though its penetrance is reduced.

Implications:

• The findings underscore the necessity of PMP22 gene sequencing for patients presenting with variable CMT phenotypes.
• Identifying PMP22 mutations expands the diagnostic spectrum for inherited neuropathies.
• Understanding genotype-phenotype correlations in PMP22-related neuropathies aids in diagnosis and potential therapeutic strategies.